Charles Lawrence Loprinzi, MD

Professor

  • 24433 Citations
  • 80 h-Index
1982 …2018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 14 Similar Profiles
Hot Flashes Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Placebos Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Peripheral Nervous System Diseases Medicine & Life Sciences
Megestrol Acetate Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1983 2015

Survivorship research established investigator award

Loprinzi, C. L.

National Institutes of Health

6/1/0812/31/13

Project: Research projectResearch Scientist Award

Survival Rate
Research Personnel
Mentors
Research
Organized Financing

CANCER CHEMOPREVENTION--ROLE OF INFECTION/IMMUNITY

Loprinzi, C. L.

National Institutes of Health

6/1/993/31/05

Project: Research projectResearch Project

Chemoprevention
Immunity
Skin Neoplasms
imiquimod
Infection

INHIBITION OF ORNITHINE DECARBOXYLASE BY ORAL COMPOUNDS

Loprinzi, C. L.

National Institutes of Health

1/1/856/30/85

Project: Research projectClinical Investigator Award (CIA)

Ornithine Decarboxylase
Skin
Tetradecanoylphorbol Acetate
Eflornithine
Retinoids

COMMUNITY CLINICAL ONCOLOGY PROGRAM

Loprinzi, C. L., Moertel, C. G., O'Connell, M., Moertel, C. G. & Moertel, C. G.

National Institutes of Health

9/15/835/31/15

Project: Research projectCooperative Clinical Research--Cooperative Agreements

Medical Oncology
Neoplasms
Research
Radiotherapy
Quality Control

Research Output 1982 2018

Building a Cardio-Onco-Hematology Program

Herrmann, J., Loprinzi, C. L. & Ruddy, K. J., Oct 1 2018, In : Current oncology reports. 20, 10, 81.

Research output: Contribution to journalReview article

Hematology
Neoplasms
Cardiovascular Diseases
Survival Rate
Hospital-Physician Joint Ventures
1 Citations

Efficacy and safety of rivaroxaban compared to enoxaparin in treatment of cancer-associated venous thromboembolism

Simmons, B., Wysokinski, W., Saadiq, R. A., Bott-Kitslaar, D., Henkin, S., Casanegra, A., Lenz, C., Daniels, P., Bjarnason, H., Vargas, E., Hodge, D., Holton, S. J., Cerhan, J. R., Loprinzi, C. L. & McBane, R., Aug 1 2018, In : European Journal of Haematology. 101, 2, p. 136-142 7 p.

Research output: Contribution to journalArticle

Enoxaparin
Second Primary Neoplasms
Venous Thromboembolism
Safety
Low Molecular Weight Heparin
Peripheral Nervous System Diseases
Incidence
International Classification of Diseases
Drug Therapy
Pain

Nasal vestibulitis: an under-recognized and under-treated side effect of cancer treatment?

Cathcart-Rake, E., Smith, D., Zahrieh, D., Jatoi, A., Yang, P. & Loprinzi, C. L., May 24 2018, (Accepted/In press) In : Supportive Care in Cancer. p. 1-6 6 p.

Research output: Contribution to journalArticle

Nose
Taxoids
Neoplasms
Vascular Endothelial Growth Factor A
Therapeutics

Oxybutynin for hot flashes due to androgen deprivation in men

Smith, T. J., Loprinzi, C. L. & Deville, C., May 3 2018, In : New England Journal of Medicine. 378, 18, p. 1745-1746 2 p.

Research output: Contribution to journalLetter

Hot Flashes
Androgens
oxybutynin